Senate amendment #1 makes the following changes to the 3rd edition.
Adds to the proposed changes to GS 90-94.1 to also allow the possession or use of cannabis extract to treat a medical condition diagnosed by a neurologist for which currently available treatment options have been ineffective (was only expanded to treat autism, multiple sclerosis, Crohn's disease, or Mitochondrial disease, in addition to the already allowable treatment of intractable epilepsy). Makes conforming modifications to the proposed changes to Article 5G, GS Chapter 90, Alternative Treatment Act, to include patients who have been diagnosed with a medical condition for which currently available treatment options have been ineffective.
Summary date: Apr 10 2019 - View summary
Summary date: Apr 3 2019 - View summary
Senate committee substitute makes the following changes to the 2nd edition.
Amends the act's long title.
Repeals Section 8.5 of SL 2015-154, which repeals Article 5G, Epilepsy Alternative Treatment Act, of GS Chapter 90, effective July 1, 2021. Effective December 1, 2019.
Summary date: Mar 20 2019 - View summary
Senate committee substitute makes the following changes to the 1st edition.
Titles the act as "Bethany's Law."
Further amends GS 90-94.1 (Exemption for use or possession of hemp extract), making the statute's provisions, as amended in the previous edition, apply to the use or possession of cannabis extract rather than hemp extract. Defines cannabis extract to mean an extract from a cannabis plant, or a mixture or preparation containing cannabis plant material, that is composed of more than 0.3% tetrahydrocannabinol by weight and less than 0.9% tetrahydrocannabinol by weight, is composed of at least 5% cannabinoids other than tetrahydrocannabinol by weight, and contains no other pyschoactive substance. Makes conforming changes.
Further amends Article 5G of GS Chapter 90 to now refer to "cannabis extract" rather than "hemp extract."
Makes clarifying changes to the definition of caregiver in GS 90-113.101.
Makes GS 90-113.101(1)d applicable to caregivers who register on or after December 1, 2019.
Amends the act's long and short titles.
Summary date: Feb 27 2019 - View summary
Amends GS 90-94.1 to also allow the possession or use of hemp extract to treat autism, multiple sclerosis, Crohn's disease, or Mitochondrial disease, in addition to the already allowable treatment of intractable epilepsy.
Amends Article 5G of GS Chapter 90 as follows. Expands the purpose of the act so that it is to allow the use of hemp extract as an alternative treatment for intractable epilepsy, autism, multiple sclerosis, Crohn's disease, and Mitochondrial disease (was, only intractable epilepsy) and renames the act as the Alternative Treatment Act to reflect the expansion. Make conforming changes to the stated General Assembly findings. Makes additional conforming changes throughout the Article to reflect the expanded allowable uses.
Expands the definition of caregiver to also include a nurse employed by a licensed home health agency, and any other caregiver of a patient who meets the already specified criteria. Expands upon the items that must be included in the neurologist's statement that the caregiver must posses, to add a statement that the patient's condition has not responded to three or more treatment options overseen by the neurologist or by a physician with whom the neurologist has consulted about the patient's condition. Also expands on the statement to allow the patient to be examined and under the care of the neurologist or a physician who has consulted with the neurologist. Adds and defines the term physician.
Amends the information that must be contained in the database registry, to also require the name, address, and hospital affiliation of any physician with whom the neurologist consults about the patient's condition in making the recommendation for hemp extract treatment. Makes conforming changes.
Effective December 1, 2019.